LOC399939 Inhibitors
LOC399939 inhibitors encompass a range of compounds that target various signaling pathways and cellular processes. The rationale for selecting these inhibitors stems from the assumption that LOC399939 is a protein that could be influenced by these pathways. For instance, kinase inhibitors like staurosporine can hinder the phosphorylation status of LOC399939 if it is a kinase or is regulated by phosphorylation.
Similarly, PI3K and mTOR inhibitors, such as LY294002 and rapamycin, respectively, may limit the activity of LOC399939 if it is a downstream effector in these signaling cascades. Inhibition of these pathways would prevent the activation of LOC399939, leading to a decrease in its functional activity Additionally, compounds like U0126 and PD98059 provide alternative approaches to dampen the ERK pathway, which could be critical if LOC399939 is regulated by this pathway.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor known to inhibit a broad spectrum of protein kinases. If LOC399939 is a kinase or is activated by phosphorylation, staurosporine can inhibit its activity by preventing phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that blocks the PI3K/Akt signaling pathway. If LOC399939 functions downstream of this pathway or is regulated by Akt, LY294002 can inhibit its activity by reducing PI3K-mediated signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, which are upstream of the ERK pathway. If LOC399939 activity is regulated by the ERK pathway, U0126 can inhibit LOC399939 by preventing its activation by ERK. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor. If LOC399939 is a substrate or is regulated by p38 MAPK, SB203580 can inhibit its function by blocking p38 MAPK activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress the mTOR pathway, which is involved in regulating cell growth and survival. If LOC399939 is an mTOR pathway component, rapamycin can inhibit its function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can prevent the degradation of proteins that regulate the cell cycle. If LOC399939 is degraded by the proteasome, bortezomib can increase its levels, potentially leading to a negative feedback loop that inhibits its functional activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin. If LOC399939 activity is calcineurin-dependent, cyclosporin A can inhibit its function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor. If LOC399939 function is regulated by chromatin structure or it interacts with histones, Trichostatin A can inhibit its activity. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
An Aurora kinase inhibitor. If LOC399939 is regulated through cell cycle checkpoints or mitosis by Aurora kinases, Alisertib can inhibit its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor, distinct from U0126, offering another route of inhibiting the ERK pathway. If LOC399939 is regulated by the ERK pathway, PD98059 can inhibit its activation. | ||||||